A detailed history of Shelton Capital Management transactions in Glaukos Corp stock. As of the latest transaction made, Shelton Capital Management holds 2,087 shares of GKOS stock, worth $326,678. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,087
Previous 2,087 -0.0%
Holding current value
$326,678
Previous $246,000 10.16%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$89.48 - $118.35 $9,663 - $12,781
-108 Reduced 4.92%
2,087 $246,000
Q1 2024

May 15, 2024

BUY
$76.4 - $96.33 $167,698 - $211,444
2,195 New
2,195 $206,000
Q3 2021

Nov 15, 2021

SELL
$47.43 - $84.23 $132,424 - $235,170
-2,792 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$48.9 - $75.26 $136,528 - $210,125
2,792 New
2,792 $210,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.